01.03.2021 Views

2016 CIOPORA Guide to Plant Breeders' Rights

CIOPORA annual magazine on Intellectual Property protection for plant innovations. Produced in cooperation with FloraCulture International. Read in the 2016 issue: - CIOPORA completes positions on Plant Breeders´ Rights - Does the U.S. miss out on additional new varieties developed abroad? - Update on the Nagoya Protocol and its EU implementation - Intellectual Property Systems: a tool, not a goal - European Trademarks and Variety : The chaos has arrived.

CIOPORA annual magazine on Intellectual Property protection for plant innovations. Produced in cooperation with FloraCulture International.

Read in the 2016 issue:
- CIOPORA completes positions on Plant Breeders´ Rights
- Does the U.S. miss out on additional new varieties developed abroad?
- Update on the Nagoya Protocol and its EU implementation
- Intellectual Property Systems: a tool, not a goal
- European Trademarks and Variety : The chaos has arrived.

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Guide</strong> To <strong>Plant</strong> <strong>Breeders'</strong> <strong>Rights</strong><br />

<strong>2016</strong><br />

The one-year window<br />

The America Invents Act, effective<br />

March 16, 2013, among<br />

other things, restates the ‘novelty’<br />

requirement for all U.S. Patents,<br />

including traditional <strong>Plant</strong> Patents.<br />

Under this standard, ‘novelty’ is<br />

now deemed <strong>to</strong> end in the United<br />

States when a plant was “on sale,<br />

or otherwise available <strong>to</strong> the public<br />

before the effective filing date”<br />

anywhere in the world. However, if<br />

the public availability was less than<br />

one year prior <strong>to</strong> the filing date of<br />

the <strong>Plant</strong> Patent Application, then<br />

it will not destroy novelty so long as<br />

the public availability was the result<br />

of actions of the breeder/inven<strong>to</strong>r<br />

(or another who obtained the<br />

plant directly or indirectly from the<br />

breeder/inven<strong>to</strong>r).<br />

Thus, though the novelty standards<br />

are similar for U.S. <strong>Plant</strong> Patents<br />

and UPOV <strong>Plant</strong> Breeder’s <strong>Rights</strong><br />

with regard <strong>to</strong> availability of the<br />

new variety within the terri<strong>to</strong>ry in<br />

which protection is being sought,<br />

they differ greatly with regard <strong>to</strong><br />

public availability outside of the<br />

terri<strong>to</strong>ry.<br />

More specifically, unlike the<br />

UPOV ‘novelty’ standard of 4 years<br />

(6 years for trees and vines) for<br />

availability outside the terri<strong>to</strong>ry, a<br />

patentability issue will likely arise<br />

for a U.S. <strong>Plant</strong> Patent if there was<br />

plant availability (sufficient for the<br />

general public <strong>to</strong> gain possession of<br />

the plant) anywhere in the world<br />

more than one year prior <strong>to</strong> the<br />

effective filing date in the United<br />

States. <strong>Plant</strong> origina<strong>to</strong>rs/inven<strong>to</strong>rs<br />

outside the U.S. need <strong>to</strong> be alert <strong>to</strong><br />

this important precondition – <strong>Plant</strong><br />

Patent protection must be timely<br />

sought in the United States once a<br />

new plant is introduced anywhere<br />

in the world.<br />

Global harmonization?<br />

Thus, one is left <strong>to</strong> reflect on whether<br />

this issue may be resulting in the<br />

United States missing out on the introduction of<br />

additional asexually reproduced plant varieties<br />

from abroad due <strong>to</strong> the owners of those new varieties<br />

being discouraged from entering the U.S. as a<br />

result of the atypically stringent ‘novelty’ standard<br />

applied <strong>to</strong> U.S. <strong>Plant</strong> Patents. For example, if an<br />

origina<strong>to</strong>r of a new plant variety introduced the<br />

new variety abroad >1 year earlier, why would he/<br />

she then bring that variety in<strong>to</strong> the U.S. when no<br />

<strong>Plant</strong> Patent protection can now be obtained?<br />

This raises the ultimate question: Should the<br />

traditional <strong>Plant</strong> Patent law of the United States<br />

(35 U.S.C. § 161 et seq.) should be modified <strong>to</strong><br />

achieve global harmonization with respect <strong>to</strong> the<br />

definitions of plant ‘novelty’? Doing so would<br />

likely make the current ‘novelty’ standard being<br />

applied more realistic in view of the unique<br />

challenges faced by persons developing new<br />

plant varieties while simultaneously providing<br />

the U.S. with the benefit of an expanded array<br />

of recently-created plants. Thus, it seems there<br />

is a strong argument that an adjustment <strong>to</strong> the<br />

novelty standard for U.S. <strong>Plant</strong> Patents would be<br />

beneficial for both plant breeders and the public<br />

as a whole. |||

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!